Samjin stocks gaining momentum

Samjin Pharm is emerging as a darling of investors on the stock market on strong earnings prospects and solid fundamentals, analysts said.

Shares of Samjin have been enjoying momentum, spurred by development of novel antiviral pyrimidinedione derivatives co-developed by the U.S. based ImQuest BioSciences Inc. and recent share split from 5,000 won per share to 1,000 won. The company closed up...